Paid Clinical Trials in Lakewood, CO
As of August 2026, 78 paid clinical trials are recruiting in Lakewood, Colorado. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lakewood offers studies at sites including Saint Anthony Hospital for conditions such as Breast Cancer, Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Colorectal Neoplasms. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lakewood
Trials by drug in Lakewood
Filter results
77 clinical trials
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Top Research Study Locations in Lakewood
Researchers run research studies in Lakewood, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Anthony Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Head and Neck Squamous Cell Carcinoma, Plasma Cell Myeloma | 15 |
| CommonSpirit Saint Anthony Hospital Cancer Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of the Colon | 11 |
| Colorado Clinical Research | Non-Muscle Invasive Bladder Neoplasms, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Neoplasms | 9 |
| Rocky Mountain Cancer Centers-Lakewood | Anatomic Stage IV Breast Cancer AJCC v8, Malignant Solid Neoplasm, Acral Lentiginous Melanoma | 7 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Breast Cancer, Breast Neoplasms | 5 |
| Colorado Retina Associates | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 5 |
| Colorado Urology | High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 3 |
| Colorado Retina Associates, PLLC | Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Degeneration | 2 |
| Rocky Mountain Cancer Centers LLP | Breast Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| Advanced Urology | Non-muscle Invasive Bladder Cancer | 1 |
| Colorado Heart and Vascular | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Colorado Retina | Macular Telangiectasia Type 2 (MacTel) | 1 |
| Colorado Retina - Lakewood | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
| Colorado Urology - St. Anthony Hospital Campus | Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 1 |
| Critical Care Pulmonary & Sleep Associates | Chronic Obstructive Pulmonary Disease | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| Lakewood | Endometriosis, Uterine Fibroids | 1 |
| Local Institution - 007-872-A | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 0340 | Non-Small Cell Lung Cancer (NSCLC) | 1 |
| Rocky Mountain Cancer Center - Lakewood | Breast Cancer | 1 |
| Rocky Mountain Cancer Centers - Lakewood | Breast Cancer | 1 |
| Rocky Mountain Gastroenterology | Crohn's Disease | 1 |
| Rocky Mountain Gastroenterology (RMG) - Littleton | Chronic Idiopathic Constipation (CIC) | 1 |
| Rocky Mountain Gastroenterology Associates - Lakewood | Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe | 1 |
| St Anthony Hospital | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Lakewood (2026)
Recruiting trials in Lakewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (43 active studies)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Eye & vision (8 active studies)
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
- Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants · Phase 4 · Neurotech Pharmaceuticals
Cardiovascular (3 active studies)
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
- Product Surveillance Registry · Medtronic
Neurology & pain (1 active study)
- Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase · University of Alabama, Tuscaloosa
Common conditions studied in Lakewood
- Breast Cancer (5 active studies)
- Malignant Solid Neoplasm (3 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- Colorectal Neoplasms (2 active studies)
- Coronary Artery Disease (2 active studies)
- Geographic Atrophy (GA) (2 active studies)
Leading research sponsors in Lakewood
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- Pfizer
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Lakewood?
There are approximately 78 recruiting clinical trials in Lakewood, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lakewood pay participants?
Most recruiting trials in Lakewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lakewood?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lakewood?
The most common conditions under active study in Lakewood include Breast Cancer (5), Malignant Solid Neoplasm (3), Anatomic Stage IV Breast Cancer AJCC v8 (2), Colorectal Neoplasms (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lakewood?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lakewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lakewood?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lakewood?
Recruiting research sites in Lakewood include Saint Anthony Hospital, CommonSpirit Saint Anthony Hospital Cancer Center, Colorado Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lakewood right now?
The largest active categories in Lakewood are Cancer & tumors (43), Eye & vision (8), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.